A randomized, double-blind, placebo-controlled study of the efficacy and safety of vortioxetine 10 mg and 20 mg in adults with major depressive disorder

Medicine & Life Sciences

• Vortioxetine 100%
• Major Depressive Disorder 61%
• Placebos 40%
• Safety 34%
• Depression 25%
• Pharmacologic Actions 6%
• Serotonin Plasma Membrane Transport Proteins 6%
• Least-Squares Analysis 5%
• Dizziness 5%
• Diagnostic and Statistical Manual of Mental Disorders 4%
• Antidepressive Agents 4%
• Nausea 4%
• Headache 4%
• Diarrhea 4%
• Psychological Inhibition 3%
• Outpatients 3%
• Anxiety 3%
• Health Care Outcome Assessment 3%
• Population 1%
• Therapeutics 1%